Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 10 (October)

1. RAR and RXR modulation in cancer and metabolic disease.
   Nat Rev Drug Discov, 6(10): 793-810. [Abstract] [Full-text]
2. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.
   Lancet, 370(9593): 1129-36. [Abstract] [Full-text]
3. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions.
   Am J Obstet Gynecol, 197(4): 404.e1-5. [Abstract] [Full-text]
4. Impact of diabetes on the severity of liver disease.
   Am J Med, 120(10): 829-34. [Abstract] [Full-text]
5. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria.
   J Am Coll Cardiol, 50(14): 1354-61. [Abstract] [Full-text]
6. Legacy of diabetes and self-care behavior.
   Res Nurs Health, 30(5): 508-17. [Abstract] [Full-text]
7. Nodular glomerular lesion: a later stage of diabetic nephropathy?
   Diabetes Res Clin Pract, 78(2): 189-95. [Abstract] [Full-text]
8. Renal hemodynamic changes and renal functional reserve in children with type I diabetes mellitus.
   Pediatr Nephrol, 22(11): 1903-9. [Abstract] [Full-text]
9. Diabetes prevalence and association with social status--widening of a social gradient? German national health surveys 1990-1992 and 1998.
   Diabetes Res Clin Pract, 78(2): 293-7. [Abstract] [Full-text]
10. Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes.
    Diabetes Res Clin Pract, 78(2): 202-7. [Abstract] [Full-text]
11. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus.
    Diabetes Res Clin Pract, 78(2): 238-45. [Abstract] [Full-text]
12. Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
    Diabetes Res Clin Pract, 78(2): 246-53. [Abstract] [Full-text]
13. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective.
    Diabetes Res Clin Pract, 78(2): 159-70. [Abstract] [Full-text]
14. Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.
    Diabetes Res Clin Pract, 78(2): 254-8. [Abstract] [Full-text]
15. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
    Diabetes Res Clin Pract, 78(2): 196-201. [Abstract] [Full-text]
16. Diabetes team consultation: impact on length of stay of diabetic patients admitted to a short-stay unit.
    Diabetes Res Clin Pract, 78(2): 211-6. [Abstract] [Full-text]
17. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes.
    Diabetes Res Clin Pract, 78(2): 259-62. [Abstract] [Full-text]
18. Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences.
    Diabetes Res Clin Pract, 78(2): 234-7. [Abstract] [Full-text]
19. Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects.
    Diabetes Res Clin Pract, 78(2): 182-8. [Abstract] [Full-text]
20. Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus.
    Diabetes Res Clin Pract, 78(2): 176-81. [Abstract] [Full-text]
21. Relevance of casual undetected hyperglycemia among high-risk individuals for developing diabetes.
    Diabetes Res Clin Pract, 78(2): 289-92. [Abstract] [Full-text]
22. Perturbation of erythrocyte antioxidant barrier, lipid peroxidation and protein carbonylation in non-diabetic first degree relatives of patients with type 2 diabetes.
    Diabetes Res Clin Pract, 78(2): 171-5. [Abstract] [Full-text]
23. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.
    Ophthalmology, 114(10): 1860-7. [Abstract] [Full-text]
24. Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Ophthalmology, 114(10): 1884-92. [Abstract] [Full-text]
25. A feasibility study of a culturally tailored diabetes intervention for Mexican Americans.
    Biol Res Nurs, 9(2): 130-41. [Abstract] [Full-text]
26. Improving quality of care for urban older people with diabetes mellitus and cardiovascular disease.
    J Am Geriatr Soc, 55(10): 1656-62. [Abstract] [Full-text]
27. Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart.
    Mol Cell Biochem, 305(1): 145-51. [Abstract] [Full-text]
28. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.
    Mol Cell Biochem, 305(1): 123-31. [Abstract] [Full-text]
29. The role of gender differences in beta-adrenergic receptor responsiveness of diabetic rat heart.
    Mol Cell Biochem, 305(1): 63-9. [Abstract] [Full-text]
30. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
    Clin Appl Thromb Hemost, 13(4): 391-7. [Abstract] [Full-text]
31. The IRF5 polymorphism in type 1 diabetes.
    J Med Genet, 44(10): 670-2. [Abstract] [Full-text]
32. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
    Biochem Biophys Res Commun, 363(2): 395-8. [Abstract] [Full-text]
33. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence.
    BMC Public Health, 7: 234. [Abstract] [Full-text]
34. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
    Tissue Antigens, 70(5): 369-75. [Abstract] [Full-text]
35. 67 th annual meeting of the American Diabetes Association.
    Expert Opin Investig Drugs, 16(10): 1735-9. [Abstract] [Full-text]
36. Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).
    Expert Opin Investig Drugs, 16(10): 1673-81. [Abstract] [Full-text]
37. Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma.
    Eur J Cancer Prev, 16(5): 471-8. [Abstract] [Full-text]
38. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Arch Ophthalmol, 125(10): 1363-6. [Abstract] [Full-text]
39. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy.
    Am J Hum Genet, 81(5): 1057-69. [Abstract] [Full-text]
40. The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors.
    BJU Int, 100(5): 1116-20. [Abstract] [Full-text]
41. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer.
    BJU Int, 100(5): 1060-5. [Abstract] [Full-text]
42. Variability in glycosylated hemoglobin values in diabetic patients living in long-term care facilities.
    J Am Med Dir Assoc, 8(8): 511-4. [Abstract] [Full-text]
43. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities.
    J Am Med Dir Assoc, 8(8): 502-10. [Abstract] [Full-text]
44. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
    J Urol, 178(5): 2203-7. [Abstract] [Full-text]
45. Diabetic urethropathy compounds the effects of diabetic cystopathy.
    J Urol, 178(5): 2213-9. [Abstract] [Full-text]
46. Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO.
    J Gen Intern Med, 22(11): 1506-13. [Abstract] [Full-text]
47. Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients.
    Chem Phys Lipids, 150(2): 204-16. [Abstract] [Full-text]
48. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
    Endocrinology, 148(11): 5136-44. [Abstract] [Full-text]
49. c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice.
    Endocrinology, 148(11): 5520-30. [Abstract] [Full-text]
50. Tuberculosis susceptibility of diabetic mice.
    Am J Respir Cell Mol Biol, 37(5): 518-24. [Abstract] [Full-text]
51. In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
    Hypertension, 50(5): 984-90. [Abstract] [Full-text]
52. Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control.
    Arterioscler Thromb Vasc Biol, 27(11): 2456-62. [Abstract] [Full-text]
53. Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method.
    J Med Virol, 79(12): 1861-7. [Abstract] [Full-text]
54. Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries.
    Br J Ophthalmol, 91(11): 1425-9. [Abstract] [Full-text]
55. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland.
    Br J Ophthalmol, 91(11): 1518-23. [Abstract] [Full-text]
56. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.
    Atherosclerosis, 195(1): e150-8. [Abstract] [Full-text]
57. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme.
    Br J Ophthalmol, 91(11): 1512-7. [Abstract] [Full-text]
58. Prevalence of cardiovascular risk factors among ethnic groups: results from the Health Surveys for England.
    Atherosclerosis, 195(1): e48-57. [Abstract] [Full-text]
59. Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and downregulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature.
    Atherosclerosis, 195(1): e1-8. [Abstract] [Full-text]
60. Effect of rosiglitazone on factors related to endothelial dysfunction in patients with type 2 diabetes mellitus.
    Atherosclerosis, 195(1): e159-66. [Abstract] [Full-text]
61. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy.
    Atherosclerosis, 195(1): 83-9. [Abstract] [Full-text]
62. One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
    J Am Coll Cardiol, 50(17): 1627-34. [Abstract] [Full-text]
63. Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.
    Hum Mutat, 28(11): 1150. [Abstract] [Full-text]
64. Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis.
    J Histochem Cytochem, 55(11): 1149-57. [Abstract] [Full-text]
65. Septin expression in proliferative retinal membranes.
    J Histochem Cytochem, 55(11): 1089-94. [Abstract] [Full-text]
66. Life style habits such as alcohol consumption and physical activity in relation to serum apoB / apoA-I ratio amongst 64-year-old women with varying degrees of glucose tolerance.
    J Intern Med, 262(5): 537-44. [Abstract] [Full-text]
67. Endocannabinoid system and cardiometabolic risk.
    Clin Pharmacol Ther, 82(5): 591-4. [Abstract] [Full-text]
68. Genetic relatedness of commensal strains of Candida albicans carried in the oral cavity of patients' dental prosthesis users in Brazil.
    Mycopathologia, 164(6): 255-63. [Abstract] [Full-text]
69. Coronary artery bypass grafting versus coronary implantation of sirolimus-eluting stents in patients with diabetic retinopathy.
    Ann Thorac Surg, 84(5): 1474-8. [Abstract] [Full-text]
70. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
    Neurology, 69(17): 1688-95. [Abstract] [Full-text]
71. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits.
    Nutr Metab Cardiovasc Dis, 17(9): 632-41. [Abstract] [Full-text]
72. The replication of beta cells in normal physiology, in disease and for therapy.
    Nat Clin Pract Endocrinol Metab, 3(11): 758-68. [Abstract] [Full-text]
73. Nodular glomerulosclerosis in a kidney transplant recipient who smokes.
    Am J Kidney Dis, 50(5): 830-3. [Abstract] [Full-text]
74. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Am J Kidney Dis, 50(5): 721-32. [Abstract] [Full-text]
75. Nonalcoholic fatty liver disease.
    Ann Epidemiol, 17(11): 863-9. [Abstract] [Full-text]
76. Expression of cannabinoid CB1 receptors in models of diabetic neuropathy.
    J Pharmacol Exp Ther, 323(2): 508-15. [Abstract] [Full-text]
77. The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.
    Ann Epidemiol, 17(11): 870-7. [Abstract] [Full-text]
78. Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients.
    Atherosclerosis, 195(1): 189-94. [Abstract] [Full-text]
79. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease.
    J Periodontal Res, 42(6): 559-65. [Abstract] [Full-text]
80. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
    N Engl J Med, 357(17): 1716-30. [Abstract] [Full-text]
81. Allogeneic islet transplantation.
    Expert Opin Biol Ther, 7(11): 1627-45. [Abstract] [Full-text]
82. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Invest Ophthalmol Vis Sci, 48(11): 5257-65. [Abstract] [Full-text]
83. Association between multifocal ERG implicit time delays and adaptation in patients with diabetes.
    Invest Ophthalmol Vis Sci, 48(11): 5250-6. [Abstract] [Full-text]
84. Comparison between the gene expression profile of human Müller cells and two spontaneous Müller cell lines.
    Invest Ophthalmol Vis Sci, 48(11): 5229-42. [Abstract] [Full-text]
85. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Invest Ophthalmol Vis Sci, 48(11): 5152-9. [Abstract] [Full-text]
86. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review.
    Invest Ophthalmol Vis Sci, 48(11): 4963-73. [Abstract] [Full-text]
87. Genetic factors in diabetic nephropathy.
    Clin J Am Soc Nephrol, 2(6): 1306-16. [Abstract] [Full-text]
88. Hypothalamic galanin and plasma leptin and ghrelin in the maintenance of energy intake in the Brattleboro rat.
    Biochem Biophys Res Commun, 364(1): 60-5. [Abstract] [Full-text]
89. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study.
    Diabetes, 56(11): 2829-33. [Abstract] [Full-text]
90. Rhinocerebral zygomycosis: an increasingly frequent challenge: update and favorable outcomes in two cases.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104(5): e28-34. [Abstract] [Full-text]
91. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion.
    J Am Coll Surg, 205(5): 631-5. [Abstract] [Full-text]
92. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface.
    Am J Ophthalmol, 144(5): 747-754. [Abstract] [Full-text]
93. Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy.
    Am J Ophthalmol, 144(5): 755-760. [Abstract] [Full-text]
94. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease.
    Diabetes, 56(11): 2655-67. [Abstract] [Full-text]
95. Abnormal connexin expression underlies delayed wound healing in diabetic skin.
    Diabetes, 56(11): 2809-17. [Abstract] [Full-text]
96. Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes.
    Diabetes, 56(11): 2697-704. [Abstract] [Full-text]
97. S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.
    Diabetes, 56(11): 2797-808. [Abstract] [Full-text]
98. Genotype by diabetes interaction effects on the detection of linkage of glomerular filtration rate to a region on chromosome 2q in Mexican Americans.
    Diabetes, 56(11): 2818-28. [Abstract] [Full-text]
99. Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes.
    Diabetes, 56(11): 2834-8. [Abstract] [Full-text]
100. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.
     Diabetes, 56(11): 2790-6. [Abstract] [Full-text]
101. Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes.
     Diabetes, 56(11): 2677-82. [Abstract] [Full-text]
102. Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling.
     Diabetes, 56(11): 2780-9. [Abstract] [Full-text]
103. IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes.
     Diabetes, 56(11): 2705-9. [Abstract] [Full-text]
104. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects.
     Diabetes, 56(11): 2683-9. [Abstract] [Full-text]
105. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
     Diabetes, 56(11): 2774-9. [Abstract] [Full-text]
106. Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: a new player in hypoglycemia unawareness?
     Diabetes, 56(11): 2766-73. [Abstract] [Full-text]
107. Best practice in primary care pathology: review 10.
     J Clin Pathol, 60(11): 1195-204. [Abstract] [Full-text]
108. Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus.
     Int J Cardiol, 122(3): e36-8. [Abstract] [Full-text]
109. CR-6 protects glutathione peroxidase activity in experimental diabetes.
     Free Radic Biol Med, 43(11): 1494-8. [Abstract] [Full-text]
110. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice.
     Biochem Pharmacol, 74(11): 1619-27. [Abstract] [Full-text]
111. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
     FASEB J, 21(13): 3653-65. [Abstract] [Full-text]
112. Major depression as a disorder of serotonin resistance: inference from diabetes mellitus type II.
     Int J Neuropsychopharmacol, 10(6): 839-50. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.